Moreover, our previous study confirmed that oncoprotein BCR-ABL can elevate expression of AURKA and AURKB through Akt signaling pathway in chronic myelogenous leukemia (CML) [112]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.